Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TUBB4A | P04350 | 1/20 | 0.51 |
| ▸ | TUBB | P07437 | 1/20 | 0.51 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.51 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.51 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.51 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.51 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.51 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.51 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.51 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.51 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.51 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.51 |
| ▸ | TUBB6 | Q9BUF5 | 1/20 | 0.51 |
| ▸ | TUBB2B | Q9BVA1 | 1/20 | 0.51 |
| ▸ | TUBB1 | Q9H4B7 | 1/20 | 0.51 |
| ▸ | CFTR | P13569 | 2/20 | 0.47 |
| ▸ | GAA | P10253 | 5/20 | 0.41 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.41 |
| ▸ | SDHB | P21912 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2437507 | 0.86 | TUBB4A (0.52) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL29656731 | 0.84 | TUBB4A (0.50) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL29110222 | 0.84 | TUBB4A (0.50) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL24761059 | 0.83 | TAS2R14 (0.44) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL125591 | 0.81 | TUBB4A (0.53) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL3878179 | 0.81 | TUBB4A (0.56) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL29110319 | 0.80 | MAPT (0.49) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL9264129 | 0.80 | TUBB4A (0.54) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL10667889 | 0.80 | TUBB4A (0.54) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL4195184 | 0.80 | LMNA (0.55) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3006444-B1 | HETEROCYCLIC AMIDE COMPOUND | NISSAN CHEMICAL IND LTD (JP) | 2017-09-27 | — | — | EP | disclosed |
| US-9708314-B2 | Heterocyclic amide compound | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2017-07-18 | — | — | US | disclosed |
| US-20160108037-A1 | HETEROCYCLIC AMIDE COMPOUND | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2016-04-21 | — | — | US | disclosed |
| EP-3006444-A1 | HETEROCYCLIC AMIDE COMPOUND | Nissan Chemical Industries, Ltd. (JP) | 2016-04-13 | — | — | EP | disclosed |
| US-20100035756-A1 | TRIAZOLOPHYRIDINE DERIVATIVES AS HERBICIDES | SYNGENTA LIMITED (GB) | 2010-02-11 | — | — | US | disclosed |
| EP-2046788-A1 | TRIAZOLOPYRIDINE DERIVATIVES AS HERBICIDES | Syngeta Participations AG (CH) | 2009-04-15 | — | — | EP | disclosed |
| WO-2008006540-A1 | TRIAZOLOPYRIDINE DERIVATIVES AS HERBICIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2008-01-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100035756-A1 | TRIAZOLOPHYRIDINE DERIVATIVES AS HERBICIDES | DDT, CYP1A1, NAT1 | TUBB4A 455/4885TUBB 180/4885TUBA3C 124/4885 |
| US-20160108037-A1 | HETEROCYCLIC AMIDE COMPOUND | H1-0, H1-3, H1-2 | TUBB4A 1183/4885TUBB 1471/4885TUBA3C 625/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.